Mumbai-based Shreya Life Sciences, known for pharmaceuticals, is reportedly exporting Nvidia AI chips to Russia despite Western sanctions. Trade records reveal Shreya’s role in rerouting Dell servers with Nvidia processors, spotlighting India’s intermediary role in Russia’s high-tech imports amid tightening restrictions.

In a discreet office building in Mumbai’s Andheri district, Shreya Life Sciences, a mid-sized pharmaceutical company, has emerged as an unexpected player in Russia’s access to high-tech equipment amid US and European Union sanctions.

According to a Bloomberg investigation, Shreya Life Sciences has become a significant intermediary in the supply of Nvidia chips to Russia, raising concerns among Western nations about India’s growing role in facilitating Moscow’s access to dual-use technology.

Analysing data from ImportGenius and NBD, Bloomberg News found that Shreya exported over 1,000 Dell PowerEdge XE9680 servers — each equipped with Nvidia’s H100 processors optimised for artificial intelligence — between April and August 2024.

These advanced servers, valued at approximately $300 million, were shipped to Russian trading firms Main Chain Ltd. and IS LLC, despite being on Western export restriction lists due to their potential military applications.